AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
OCTREOTIDE in Tunisia
5 products registered with DPM — 0 active, 5 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| OCTREOTIDE NEAPOLIS Solution injectable / 0.1 mg/ml | 9393181H | NEAPOLIS PHARMA | expired | 30 Mar 2021 |
| SANDOSTATINE L.A.R. Poudre pour suspension injectable / 30 mg | 10283183H | NOVARTIS PHARMA SCHWEIZ AG | expired | 10 Sept 2013 |
| SANDOSTATINE LAR Poudre pour suspension injectable / 20 mg | 10283184H | NOVARTIS PHARMA SCHWEIZ AG | expired | 10 Sept 2013 |
| SANDOSTATINE Solution injectable / 0.05 mg/ml | 10283181H | NOVARTIS PHARMA SCHWEIZ AG | expired | 16 Oct 2007 |
| SANDOSTATINE Solution injectable / 0.1 mg/ml | 10283182H | NOVARTIS PHARMA SCHWEIZ AG | expired | 16 Oct 2007 |
OCTREOTIDE — DPM Registration Details
DPM (Tunisia) has 5 registered products containing OCTREOTIDE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track OCTREOTIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.